Articles dans des revues avec comité de lecture (45)
  1. 13. Van Rees, D. D., Bouti, P., Klein, B., Verkuijlen, P. P., Van Houdt, M., Schornagel, K., Tool, A. A., Venet, D., Sotiriou, C., El-abed, S., Izquierdo, M., Guillaume, S., Saura, C., Di Cosimo, S., Huober, J., Roylance, R., Kim, S.-B., Kuijpers, T. W., Van Bruggen, R., K Van Den Berg, T., & Matlung, H. H. (2022). Cancer cells resist antibody-mediated destruction by neutrophils through activation of the exocyst complex. Journal for ImmunoTherapy of Cancer, 10(6), e004820. doi:10.1136/jitc-2022-004820
  2. 14. Chang, C. A., Jen, J., Jiang, S., Sayad, A., Mer, A. S., Brown, K. R., Nixon, A. M. L., Dhabaria, A., Tang, K. H., Venet, D., Sotiriou, C., Deng, J., Wong, K. K., Adams, S., Meyn, P., Heguy, A., Skok, J. A., Tsirigos, A., Ueberheide, B., Moffat, J., Singh, A., Haibe-Kains, B., Khodadadi-Jamayran, A., & Neel, B. G. (2022). Ontogeny and Vulnerabilities of Drug-Tolerant Persisters in HER2+ Breast Cancer. Cancer Discovery, 12(4), 1022-1045. doi:10.1158/2159-8290.CD-20-1265
  3. 15. Gombos, A., Venet, D., Ameye, L., Vuylsteke, P., Neven, P., Richard, V., Duhoux, F. F., Laes, J.-F., Rothé, F., Sotiriou, C., Paesmans, M., Awada, A., Guiot, T., Flamen, P., Piccart-Gebhart, M., Ignatiadis, M., & Gebhart, G. (2021). FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer. NPJ breast cancer, 7(1), 125. doi:10.1038/s41523-021-00331-8
  4. 16. Venet, D., Rediti, M., Maetens, M. M., Fumagalli, D., Brown, D. N., Majjaj, S., Salgado, R., Pusztai, L., Harbeck, N., El-Abed, S., Wang, Y., Saura, C., Gomez, H., Semiglazov, V. F., de Azambuja, E., Huober, J., Nuciforo, P. G., Di Cosimo, S., Piccart-Gebhart, M., Loi, S., Rothé, F., & Sotiriou, C. (2021). Copy number aberration analysis to predict response to neoadjuvant antiHER2 therapy: results from the NeoALTTO phase III clinical trial. Clinical cancer research, 27(20), 5607-5618. doi:10.1158/1078-0432.CCR-21-1317
  5. 17. Aftimos, P., Oliveira, M., Irrthum, A., Fumagalli, D., Sotiriou, C., Nili Gal-Yam, E., Robson, M. M., Ndozeng, J., Di Leo, A., Ciruelos, E. M., de Azambuja, E., Viale, G., Scheepers, E. D., Curigliano, G., Bliss, J. M., Reis-Filho, J. S., Colleoni, M. A., Balic, M., Cardoso, F., Albanell, J., Duhem, C., Marreaud, S., Romagnoli, D., Rojas, B., Gombos, A., Wildiers, H., Guerrero-Zotano, A., Hall, P., Bonetti, A., Larsson, K. F., Degiorgis, M., Khodaverdi, S., Greil, R., Sverrisdottir, A., Paoli, M., Seyll, E., Loibl, S., Linderholm, B. B., Zoppoli, G., Davidson, N. E., Johannsson, O. T., Bedard, P. L., Loi, S., Knox, S., Cameron, D. A., Harbeck, N., Lasa Montoya, M., Brandão, M., Vingiani, A., Caballero, C., Hilbers, F. S., Yates, L. R., Benelli, M., Venet, D., & Piccart, M. J. (2021). Genomic and transcriptomic analyses of breast cancer primaries and matched metastases in AURORA, the Breast International Group (BIG) molecular screening initiative. Cancer discovery. doi:10.1158/2159-8290.CD-20-1647
  6. 18. Richard, F., Majjaj, S., Venet, D., Rothé, F., Pingitore, J., Boeckx, B., Marchio, C., Clatot, F., Bertucci, F., Mariani, O., Galant, C., Eynden, G. V. D., Salgado, R., Biganzoli, E., Lambrechts, D., Vincent-Salomon, A., Pruneri, G., Larsimont, D., Sotiriou, C., & Desmedt, C. (2020). Characterization of Stromal Tumor-infiltrating Lymphocytes and Genomic Alterations in Metastatic Lobular Breast Cancer. Clinical cancer research, 26(23), 6254-6265. doi:10.1158/1078-0432.CCR-20-2268
  7. 19. Venet, D., Fimereli, D., Rothé, F., Boeckx, B., Maetens, M., Majjaj, S., Rouas, G., Capra, M., Bonizzi, G., Contaldo, F., Galant, C., Piccart, M., Pruneri, G., Larsimont, D., Lambrechts, D., Desmedt, C., & Sotiriou, C. (2020). Phylogenetic reconstruction of breast cancer reveals two routes of metastatic dissemination associated with distinct clinical outcome. EBioMedicine, 56, 102793. doi:10.1016/j.ebiom.2020.102793
  8. 20. Gómez-Aleza, C., Nguyen, B., Yoldi, G., Ciscar, M., Barranco, A., Hernández-Jiménez, E., Maetens, M., Salgado, R., Zafeiroglou, M., Pellegrini, P., Venet, D., Garaud, S., Trinidad, E. M., Benítez, S., Vuylsteke, P., Polastro, L., Wildiers, H., Simon, P., Lindeman, G. G., Larsimont, D., Van den Eynden, G., Velghe, C., Rothé, F., Willard-Gallo, K., Michiels, S., Muñoz, P., Walzer, T., Planelles, L., Penninger, J., Azim, H. A., Loi, S., Piccart, M., Sotiriou, C., & González-Suárez, E. (2020). Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+ T cells. Nature communications, 11(1), 6335. doi:10.1038/s41467-020-20138-8
  9. 21. Bareche, Y., Buisseret, L., Gruosso, T., Girard, E., Venet, D., Dupont, F., Desmedt, C., Larsimont, D., Park, M., Rothé, F., Stagg, J., & Sotiriou, C. (2019). Unraveling triple-negative breast cancer tumor microenvironment heterogeneity: towards an optimized treatment approach. Journal of the National Cancer Institute. doi:10.1093/jnci/djz208
  10. 22. Rothé, F., Silva, M. J., Venet, D., Campbell, C., Bradburry, I., Rouas, G., de Azambuja, E., Maetens, M., Fumagalli, D., Rodrik-Outmezguine, V., Di Cosimo, S., Rosa, D., Chia, S., Wardley, A., Ueno, T., Janni, W., Huober, J., Baselga, J., Piccart-Gebhart, M., Loi, S., Sotiriou, C., Dawson, S. J., & Ignatiadis, M. (2019). Circulating Tumor DNA in HER2-Amplified Breast Cancer: A Translational Research Substudy of the NeoALTTO Phase III Trial. Clinical cancer research, 25(12), 3581-3588. doi:10.1158/1078-0432.CCR-18-2521
  11. 23. Nguyen, B., Venet, D., Lambertini, M., Desmedt, C., Salgado, R., Horlings, H. M., Rothé, F., & Sotiriou, C. (2019). Imprint of parity and age at first pregnancy on the genomic landscape of subsequent breast cancer. Breast cancer research, 21(1), 25. doi:10.1186/s13058-019-1111-6
  12. 24. Hanker, A. B., Garrett, J. T., Estrada, M. V., Moore, P. D., Ericsson, P. G., Koch, J. P., Langley, E., Singh, S., Kim, P. S., Frampton, G. M., Sanford, E., Owens, P., Becker, J., Groseclose, R. M., Castellino, S., Joensuu, H., Huober, J., Brase, J. C., Majjaj, S., Brohée, S., Venet, D., Brown, D., Baselga, J., Piccart-Gebhart, M., Sotiriou, C., & Arteaga, C. L. (2019). Correction: HER2-Overexpressing Breast Cancers Amplify FGFR Signaling upon Acquisition of Resistance to Dual Therapeutic Blockade of HER2. Clinical cancer research, 25(4), 1434. doi:10.1158/1078-0432.CCR-18-4267
    13. << Précédent 1 2 3 4 5 Suivant >>